A Single Group Study to Evaluate the Efficacy of a Cosmetic Product Line on Acne Symptoms

Menning Labs

Status

Completed

Conditions

Acne

Treatments

Other: EQ Gel

Other: EQ Exfoliating Cleanser

Other: EQ Moisturizer

Study type

Interventional

Funder types

Industry

Identifiers

NCT06122467

20365

Details and patient eligibility

About

This twelve-week trial will examine the effectiveness of a Menning Labs EQ Product Line acne product. Participants will use the exfoliating cleanser, cream, and gel daily for 8 weeks. Participants will complete questionnaires at Baseline, Day 1, Day 3, Day 7, Day 28, Day 42, and Day 56. Participants will also provide before-and-after photos at Baseline, Day 7, and Day 42, as well as undergo expert skin grading at Baseline and Day 42. The questionnaire on Day 56 will mark the conclusion of the trial.

Enrollment

36 patients

Sex

All

Ages

18 to 45 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

Be aged between 18-45.
Anyone who has acne prone skin and a history of recurring acne.
Has visible acne at enrollment.
Anyone who is generally healthy - does not live with any uncontrolled chronic disease.
Have a digital camera or smartphone to take photos of the face.

Exclusion criteria

Anyone with pre-existing chronic conditions that would prevent participants from adhering to the protocol, including oncological and psychiatric disorders.
Anyone currently using a prescription skin product.
Anyone who is unwilling to stop using the current acne supplements they are taking.
Anyone with known severe allergic reactions.
Any women who are pregnant, breastfeeding or attempting to become pregnant.
Anyone unwilling to follow the study protocol.
Anyone who identifies as having sensitive skin.